viewCello Health PLC

Vibrant US sector putting a tailwind behind Cello Health says CEO Scott

A vibrant US healthcare sector is generating good momentum for Cello Health PLC (LON:CLL), says chief executive Mark Scott.

R&D spending and innovation are high, which is driving business towards its healthcare communications and consulting arms.

Existing accounts are growing while the addition of new customers is strong, he told Proactive.

Cello is also generating plenty of cash, he adds and unless it makes another sizeable purchase should finish the year with a healthy balance.

Scott wants to add to the company’s footprint in the US, though he says prices in the US reflect just how strong the market there is at present.

Quick facts: Cello Health PLC

Price: - -

Market: AIM
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...


Market Report: FTSE lacks direction as investors await next big market mover

The London bourse is slightly lower this Wednesday with US data pointing towards a potentially painful recession. More doom for the tourism industry following the news Princess Cruises (LON:CLL) said it would cancel early 2021 cruises on two ships due to the COVID-19 pandemic...

on 26/8/20

2 min read